Coronary ostial eccentricity in severe aortic stenosis: Guidance for BASILICA transcatheter leaflet laceration.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 20 10 2019
revised: 08 02 2020
accepted: 25 02 2020
pubmed: 23 3 2020
medline: 6 1 2021
entrez: 23 3 2020
Statut: ppublish

Résumé

Eccentricity of coronary ostial positions in relation to the aortic valve cusp may influence the target laceration location in BASILICA (Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Coronary Artery obstruction). Eccentricity of the coronary ostia in relation to coronary cusps of native and valve-in-valve transcatheter aortic valve replacement (TAVR) was not well described before. A total of 121 pre-TAVR patients' CT data (72 native valves TAVR and 49 bioprosthetic surgical valves TAVR) was included and coronary ostial eccentricity angles were measured and compared. Coronary ostial angles were measured between mid-cusp line to coronary ostium in CT perpendicular images. In the overall cohort, the right coronary artery (RCA) had an eccentric origin in the majority of cases, favoring the commissure between the right and the non coronary cusp (17.0°, IQR; 10-25). On the other hand, the left coronary artery (LCA) originated most commonly near center of the cusp position (0°, IQR; -8 -7.5) In comparison of native and bioprosthetic valves, RCA ostial angles were more eccentric in native valves (19.0°, IQR; 12-26) than in bioprosthetic valves (14.0°, IQR; 3-20) (p = 0.004). Whereas, LCA ostial angle has no significant differences between native valves (-2.0°, IQR;-7.75-5.75) and bioprosthetic valves (1°, IQR;-8-13), (p = 0.6). RCA ostia often have an eccentric origin towards the non-coronary cusp, especially in native aortic valves, while LCA ostia commonly originate near the center of the cusp. This finding may contribute to better performance of BASILICA procedures.

Sections du résumé

BACKGROUND BACKGROUND
Eccentricity of coronary ostial positions in relation to the aortic valve cusp may influence the target laceration location in BASILICA (Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Coronary Artery obstruction). Eccentricity of the coronary ostia in relation to coronary cusps of native and valve-in-valve transcatheter aortic valve replacement (TAVR) was not well described before.
METHODS METHODS
A total of 121 pre-TAVR patients' CT data (72 native valves TAVR and 49 bioprosthetic surgical valves TAVR) was included and coronary ostial eccentricity angles were measured and compared. Coronary ostial angles were measured between mid-cusp line to coronary ostium in CT perpendicular images.
RESULTS RESULTS
In the overall cohort, the right coronary artery (RCA) had an eccentric origin in the majority of cases, favoring the commissure between the right and the non coronary cusp (17.0°, IQR; 10-25). On the other hand, the left coronary artery (LCA) originated most commonly near center of the cusp position (0°, IQR; -8 -7.5) In comparison of native and bioprosthetic valves, RCA ostial angles were more eccentric in native valves (19.0°, IQR; 12-26) than in bioprosthetic valves (14.0°, IQR; 3-20) (p = 0.004). Whereas, LCA ostial angle has no significant differences between native valves (-2.0°, IQR;-7.75-5.75) and bioprosthetic valves (1°, IQR;-8-13), (p = 0.6).
CONCLUSION CONCLUSIONS
RCA ostia often have an eccentric origin towards the non-coronary cusp, especially in native aortic valves, while LCA ostia commonly originate near the center of the cusp. This finding may contribute to better performance of BASILICA procedures.

Identifiants

pubmed: 32199758
pii: S1934-5925(20)30103-9
doi: 10.1016/j.jcct.2020.02.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-519

Informations de copyright

Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr HC Wijeysundera received research funding from Medtronic Inc and Edwards Lifesciences. Dr.JM McCabe is a consultant to Edwards LifeSciences, Boston Scientific. Dr N Piazza is a consultant and proctor for Medtronic and Microport. D Dvir, is a consultant to Edwards Lifesciences, Medtronic, Gore, Jena, Abbott. All other authors have no potential conflicts of interest to disclose with regard to any part of the data or results in this report.

Auteurs

Ikki Komatsu (I)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Jonathon Leipsic (J)

Department of Radiology, St Paul's Hospital & University of British Columbia, Vancouver, British Columbia, Canada.

John G Webb (JG)

Center for Heart Valve Innovation, St Paul's Hospital, Vancouver, British Columbia, Canada.

Philipp Blanke (P)

Department of Radiology, St Paul's Hospital & University of British Columbia, Vancouver, British Columbia, Canada.

G Burkhard Mackensen (GB)

Division of Cardiothoracic Anesthesiology, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.

Creighton W Don (CW)

Division of Cardiology, University of Washington, Seattle, WA, USA.

James M McCabe (JM)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Christopher Rumer (C)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Christina W Tan (CW)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Dmitry B Levin (DB)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Mario Ramos (M)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Gabriel S Aldea (GS)

Division of Cardiovascular Surgery, University of Washington, Seattle, WA, USA.

Mark Reisman (M)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Harindra C Wijeysundera (HC)

Department of Cardiology, Sunnybrook Health Sciences Center, Toronto, Canada.

Sam Radhakrishnan (S)

Department of Cardiology, Sunnybrook Health Sciences Center, Toronto, Canada.

Janarthanan Sathananthan (J)

Center for Heart Valve Innovation, St Paul's Hospital, Vancouver, British Columbia, Canada.

Nicolo Piazza (N)

Department of Medicine, Division of Cardiology, McGill University, Montreal, Quebec, Canada.

Ran Kornowski (R)

Division of Interventional Cardiology, Rabin Medical Center, Petah Tikva, Israel.

Danny Dvir (D)

Division of Cardiology, University of Washington, Seattle, WA, USA. Electronic address: danny.dvir@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH